0001209191-22-027164.txt : 20220504 0001209191-22-027164.hdr.sgml : 20220504 20220504171743 ACCESSION NUMBER: 0001209191-22-027164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220503 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Metcalfe David A CENTRAL INDEX KEY: 0001664295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12537 FILM NUMBER: 22892646 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC. CENTRAL INDEX KEY: 0000708818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 952888568 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 BUSINESS PHONE: 404-467-1500 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20100804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-03 0 0000708818 NEXTGEN HEALTHCARE, INC. NXGN 0001664295 Metcalfe David A 3525 PIEDMONT RD., NE BUILDING 6, SUITE 700 ATLANTA GA 30305 0 1 0 0 Chief Technology Officer Common Stock 2022-05-03 4 M 0 16162 14.20 A 171175 D Common Stock 2022-05-03 4 M 0 17676 14.07 A 188851 D Common Stock 2022-05-03 4 S 0 33838 20.0019 D 155013 D Stock Option (right to buy) 14.20 2022-05-03 4 M 0 16162 0.00 D 2024-02-01 Common Stock 16162 150000 D Stock Option (right to buy) 14.07 2022-05-03 4 M 0 17676 0.00 D 2025-10-31 Common Stock 17676 122324 D Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.085. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request. Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017. Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018. /s/ Jeffrey D. Linton, Attorney-in-Fact for David A.Metcalfe 2022-05-04